YOUR BUSINESS AUTHORITY
Springfield, MO
The Federal Trade Commission yesterday cleared Roche's $4.8 billion buyout of Spark Therapeutics.
The approval comes after 10 months of antitrust investigations.
Earlier on Monday, the U.K. Competition and Markets Authority gave the green light to the deal.
Read more from Biopharma Dive.